64.62
Tempus Ai Inc 주식(TEM)의 최신 뉴스
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI - CryptoRank
Tempus AI (NASDAQ:TEM): Can Growth Outrun Rate Risks? - Kalkine Media
Best Artificial Intelligence Stocks To ConsiderSeptember 7th - MarketBeat
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - tradingview.com
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS) - Seeking Alpha
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc. - MarketBeat
Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM - MarketBeat
Tracking Cathie Wood: Loading Up on Gene Editing and Precision Medicine, Trimming Tempus AI and Synthetic Biology - Moomoo
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM - MarketBeat
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
Tempus AI Stock (TEM) Opinions on Analyst Upgrades and Personalized Medicine Momentum - Quiver Quantitative
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
Tempus AI Director Jennifer A. Doudna Sells 676 Shares Under Rule 10b5-1 Plan - Kalkine Media
Tempus AI Data CEO Ryan Fukushima's Spouse Executes $30,846 Share Sale via 10b5-1 Plan - Kalkine Media
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan - Stock Titan
Tempus AI (TEM) director’s stock sale follows preset plan - Stock Titan
Tempus AI (TEM) director sells 676 shares under preset plan - Stock Titan
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat? - Yahoo Finance
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says - Benzinga
Cantor Fitzgerald initiates Tempus AI stock with overweight rating By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Watch TodaySeptember 2nd - MarketBeat
Tempus AI gains as Cantor issues new Overweight on Data and applications segment - Seeking Alpha
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 - The Motley Fool
Tempus AI (NASDAQ:TEM) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald initiates Tempus AI stock with overweight rating - Investing.com
Cantor Fitzgerald Initiates Tempus AI at Overweight With $80 Price Target - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB) - The Globe and Mail
Cathie Wood's Investment Moves on September 1! Significantly Increased Stake in Rocket Lab, Reduced Holdings in Tempus AI - Moomoo
Tempus AI Inc (Derivatives) to Euro Price Today | Live TEM to EUR Converter & Exchange Rate - CryptoRank
Cathie Wood Sells $15.6 Million of Tempus AI Stock After Merck-Moderna Trial Win, Ark Keeps Selling AMD Shares - Benzinga
Tempus AI Director Nadja West Sells 3,000 Class A Shares Under Rule 10b5-1 Plan - Kalkine Media
Nadja West Sells 3,000 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Tempus AI (TEM) director sells 3K shares, still holds 31,981 - Stock Titan
Tempus AI Inc (Derivatives) to Japanese Yen Price Today | Live TEM to JPY Converter & Exchange Rate - CryptoRank
Tempus AI (NASDAQ:TEM) Shares Gap UpShould You Buy? - MarketBeat
Tempus AI stock upgraded at Piper Sandler (TEM:NASDAQ) - Seeking Alpha
Tempus AI shares rise 2.7% following analyst actions - Yahoo Finance
Tempus AI Inc (Derivatives) to United States Dollar Price Today | Live TEM to USD Converter & Exchange Rate - CryptoRank
Tempus AI stock rises on Piper Sandler upgrade to Overweight By Investing.com - Investing.com Nigeria
Tempus AI stock rises on Piper Sandler upgrade to Overweight - Investing.com
Tempus AI Inc (Derivatives) to Russian Ruble Price Today | Live TEM to RUB Converter & Exchange Rate - CryptoRank
Tempus AI Inc (Derivatives) to Chinese Yuan Price Today | Live TEM to CNY Converter & Exchange Rate - CryptoRank
Piper Sandler upgrades Tempus AI stock rating on acquisition benefits - Investing.com
Piper Sandler upgrades Tempus AI stock rating on acquisition benefits By Investing.com - Investing.com Nigeria
Piper Sandler Upgrades Tempus AI(TEM.US) to Buy Rating, Raises Target Price to $76 - Moomoo
Canaccord reiterates Tempus AI stock rating on acquisition synergies By Investing.com - Investing.com Nigeria
Canaccord reiterates Tempus AI stock rating on acquisition synergies - Investing.com
Tempus AI Inc (Derivatives) to Indonesian Rupiah Price Today | Live TEM to IDR Converter & Exchange Rate - CryptoRank
Tempus AI Inc (Derivatives) Price | TEM Price Today, Live Chart, USD converter, Market Capitalization - CryptoRank
Tempus AI, Inc. (TEM) Stock Analysis: Navigating a Healthcare Tech Leader with Diverse Strategic Collaborations - directorstalkinterviews.com
46,411 Shares in Tempus AI, Inc. $TEM Bought by Headlands Technologies LLC - MarketBeat
Artificial Intelligence Stocks To ConsiderAugust 30th - MarketBeat
Tempus AI Inc (Derivatives) price today, TEM to USD live price, marketcap and chart - CoinMarketCap
Tempus AI (TEM) CEO sells 11.8K shares at $70 on August 25, 2026 - Stock Titan
Tempus AI (TEM) insider sells shares under preset trading plan - Stock Titan
Tempus AI CEO Eric Lefkofsky sells over $16.2 million in company stock - Investing.com
Tempus AI, Inc. Tokenized Stock (Robinhood) Analytics - CryptoRank
Guardant Suits Against Tempus AI Clear Dismissal Bids - Law360
Tempus AI Can’t Shake Guardant Lawsuits Over Diagnostic Tests - Bloomberg Law News
15,476 Shares in Tempus AI, Inc. $TEM Bought by Odyssean LLC - MarketBeat
Tempus AI (TEM) exec's spouse sells 14K shares under preset plan - Stock Titan
Study Backs Efficacy of Tempus AI’s Afib Risk Prediction Technology - Medical Product Outsourcing
Tempus AI (TEM) diagnostics CEO trades shares under 10b5-1 plan - Stock Titan
What’s Going On With Tempus AI Stock on Monday? - tradingview.com
FDA clears Tempus AI's third cardiovascular device for pulmonary hypertension detection - Medical Economics
Tempus AI Inc Stock (TEM) Moved Down by 7.10% on Aug 24: Key Drivers Unveiled - TradingKey
Why Tempus AI Skyrocketed This Week - Yahoo Finance
Tempus AI's Diagnostics Chief Filed Stock Sales Spanning a Volatile Week. Here's What Happened - The Motley Fool
Has Tempus AI (TEM) Run Too Far Ahead Of Its Valuation Narrative? - Yahoo Finance
Tempus AI Options Spot-On: On August 21st, 135.55K Contracts Were Traded, With 417.55K Open Interest - Moomoo
Tempus AI (NASDAQ: TEM) insider plans fresh sale after recent stock disposals - Stock Titan
Tempus AI (TEM) officer to sell 2,694 shares, details past sales - Stock Titan
Tempus AI Inc Stock (TEM) Moved Up by 8.36% on Aug 21: Drivers Behind the Movement - TradingKey
TEM rises nearly 9% as robust revenue growth and bullish technical signals drive gains - Traders Union
Tempus AI (NASDAQ:TEM) Trading 8.3% Higher on Analyst Upgrade - MarketBeat
Tempus AI Soars on Cancer Breakthrough and Bold Upgrade - TipRanks
자본화:
|
볼륨(24시간):